Skip to main content
. Author manuscript; available in PMC: 2010 Oct 8.
Published in final edited form as: Curr Treat Options Neurol. 2007 Sep;9(5):337–346.

Table 1.

Insomnia pharmacotherapy drugs and main features

Drug Mechanism of action Approved dose, mg Half-life, hours Initiates sleep Maintains sleep Sleep with limited opportunity Required inactivity
Eszopiclone BzRA 1, 2, 3 6 Yes Yes 8+ hours
Zaleplon BzRA 5, 10, 20 1 Yes Yes 4 hours
Zolpidem BzRA 5, 10 1.4–4.5 Yes 7–8 hours
Zolpidem controlled-release BzRA 6.5, 12.5 2.8–2.9 Yes Yes 7–8 hours
Ramelteon Melatonin receptor agonist 8 2–5 Yes Not applicable

BzRA—benzodiazepine receptor agonist.